Table 2.
Absolute and relative frequencies of the use of medications in the preoperative period according to the study group.
| Variables | Original Cohort (n=2,688) | ||
|---|---|---|---|
| Diabetes | P value | ||
| No (n=1,698) | Yes (n=990) | ||
| Anticoagulant | 8 (0.5) | 6 (0.6) | 0.639[1] |
| Acetylsalicylic acid | 1,158 (68.2) | 710 (71.2) | 0.056[1] |
| Beta blocker | 1,107 (65.2) | 611 (61.7) | 0.070[1] |
| Oral nitrates | 1,106 (65.1) | 577 (58.3) | <0.00[1] |
| Calcium-channel blocker | 308 (18.1) | 226 (22.8) | 0.003[1] |
| Diuretics | 431 (25.4) | 282 (28.5) | 0.079[1] |
| Angiotensin-converting enzyme inhibitors | 790 (46.5) | 500 (50.5) | 0.046[1] |
| Angiotensin II receptor blockers | 271 (16.0) | 200 (20.2) | 0.005[1] |
| Inotropic agents | 3 (0.2) | 2 (0.2) | 1.000[2] |
| Statins | 1,164 (68.6) | 646 (65.3) | 0.079[1] |
[1]
Descriptive level of probability determined by the chi-square test.
[2]
Descriptive level of probability determined by the Fisher1s exact test.